Native Proteins and Derivatives
Abcam Native Astrovirus type 1 protein.
This product is for research use only and not for diagnostic or therapeutic procedures. Customer is granted a limited, non-exclusive license for internal research and shall not attempt to reverse engineer.
Native Astrovirus type 1 protein.
Abcam Geldanamycin, Hsp90 inhibitor, 1MG
MW 560.64 g/mol, Purity >98%. Selective Hsp90 inhibitor. Binds the ATP site of Hsp90 and inhibits chaperone activity. A benzoquinone ansamycin antibiotic. Also inhibits the Hsp90 paralog GRP94. Exhibits various cellular actions including gene expression, cell proliferation, apoptosis and angiogenesis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Diclofenac sodium salt, cyclo-o x ygenase inhibitor, 1G
MW 318.13 g/mol, Purity >99%. Potent non-selective COX inhibitor (IC₅₀ values are 75 and 29 nM at COX-1 and COX-2, respectively). Potent inhibitor of phospholipase A₂ in vitro and in vivo. Activates the nitric oxide-cyclic GMP-potassium channel pathway. Shows anti-inflammatory, antipyretic and analgesic effects.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Sitagliptin Phosphate Monohydrate, 100MG
MW 523.32 Da, Purity >=98%. Anti-diabetic (antihyperglycemic) drug of the dipeptidyl peptidase-4 (DPP-4) class. Inhibition of the enzyme DPP-4 is thought to increase Glucagon-like peptide-1 (GLP-1) which inhibits glucagon release , stimulates the insulin release and lowers blood glucose.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Tanespimycin (17-AAG), HSP90 inhibitor, 5MG
MW 585.7 Da, Purity >98%. Potent, selective HSP90 inhibitor (IC₅₀ = 5 nM). Anticancer activity, including cytostatic, proapoptotic and antiangiogenic properties in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ALLM, calpain inhibitor, 5MG
MW 401.6 Da, Purity >95%. ALLM, calpain inhibitor. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Biolegend PE/Cyanine7 anti-mouse CD107a
PE/Cyanine7 anti-mouse CD107a (LAMP-1) [1D4B]; Isotype: Rat IgG2a, κ; Reactivity: Mouse; Apps: FC; Size: 25 μg
Biolegend Alexa FluorR 594 anti-mouse CD
Alexa Fluor 594 anti-mouse CD107a (LAMP-1) [1D4B]; Isotype: Rat IgG2a, κ; Reactivity: Mouse; Apps: IHC-F; Size: 100 μg
Biolegend Ultra-LEAFTM Purified anti-hum
Ultra-LEAF™ Purified anti-human PLAUR (uPAR) [A20095H]; Isotype: Mouse IgM, κ; Reactivity: Human; Apps: Block; Size: 1 mg
Biolegend Recombinant Human Activin A ca
Recombinant Human Activin A (carrier-free); Reactivity: Human; Apps: BA; Size: 25 μg
Biolegend Purified anti-Neurofilament H
Purified anti-Neurofilament H (NF-H), Phosphorylated [SMI 34]; Isotype: Mouse IgG1, κ; Reactivity: Human, Mouse, Rat; Apps: IHC-P, WB; Size: 25 μg
AMERICAN RESEARCH PRODUCTS INC HIGH-DENSITY LIPOPROTEIN KIT
50-302-9861 HIGH-DENSITY LIPOPROTEIN KIT
Cayman Chemical 17mthyl StearIc ACD mthyl 20mg
A semisyntheticBlactam antibiotic active against clinical isolates of methicillin-susceptible S. aureus and penicillin-susceptible S. pneumoniae as well as group A group B and viridans group streptococci in vitro (MIC90s 0.06-2 Ug/ml) less effective toward other bacteria (MIC90 16 Ug/ml for S. epidermidis S. haemolyticus E. faecalis E. faecium MRSA and penicillin-intermediate and -resistant S. pneumoniae) targets the bacterial cell wall inhibits S. pneumoniae penicillin-binding proteins 1a 1b 2a 2b and 3 in vitro (IC50s 0.17-1.75 UM) inhibits growth of S. aureus in a thigh model of infection in mice (ED50 45.19 mg/kg s.c.)
American Research Products Inc Anti FN1 Fibronectin F8 IL12
Anti-Human FN1/Fibronectin (F8-IL12) Research Grade